Fritzberg et al., 1981 - Google Patents
Chemical and biological studies of Tc-99m N, N′-bis (mercaptoacetamido) ethylenediamine: A potential replacement for I-131 iodohippurateFritzberg et al., 1981
View PDF- Document ID
- 10104777375664168645
- Author
- Fritzberg A
- Klingensmith W
- Whitney W
- Kuni C
- Publication year
- Publication venue
- Journal of Nuclear Medicine
External Links
Snippet
Chemical and Biological Studies of Tc-99m N,N'-Bis(mercaptoacetamido)- ethylenediamine:
A Potential Replacement for 1-131 lodohi Page 1 Chemical and Biological Studies of Tc-99m
N,N'-Bis(mercaptoacetamido)- ethylenediamine: A Potential Replacement for 1-131 …
- ZCYVEMRRCGMTRW-RNFDNDRNSA-N I-131 data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [131I] 0 title description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0476—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fritzberg et al. | Chemical and biological studies of Tc-99m N, N′-bis (mercaptoacetamido) ethylenediamine: A potential replacement for I-131 iodohippurate | |
Fritzberg et al. | Synthesis and Biological Evaluation of Tc-99m N, N′-Bis (mercaptoacetyl)-2, 3-diaminopropanoate: A Potential Replacement for [131I] o-iodohippurate | |
John et al. | Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis (thiosemicarbazonato) copper (II) derivatives | |
Ogawa et al. | Development of a novel 99mTc-chelate–conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent | |
Yokoyama et al. | The design of a pentavalent 99mTc− dimercaptosuccinate complex as a tumor imaging agent | |
Marques et al. | 13-and 14-membered macrocyclic ligands containing methylcarboxylate or methylphosphonate pendant arms: chemical and biological evaluation of their 153Sm and 166Ho complexes as potential agents for therapy or bone pain palliation | |
US4923969A (en) | Preparation of 99m Tc radiopharmaceuticals | |
Bubeck et al. | Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine) | |
Loberg et al. | Membrane transport of Tc-99m-labeled radiopharmaceuticals. I. Brain uptake by passive transport | |
Shattuck et al. | Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity | |
Baldas et al. | Effect of the Tc-nitrido group on the behaviour of 99mTc-radiopharmaceuticals | |
Fritzberg et al. | HPLC analysis of Tc-99m iminodiacetate hepatobiliary agents and a question of multiple peaks: concise communication | |
Sun et al. | In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands | |
Rajagopalan et al. | Preparation, characterization, and biological evaluation of technetium (V) and rhenium (V) complexes of novel heterocyclic tetradentate N3S ligands | |
Marques et al. | 153 Sm and 166 Ho complexes with tetraaza macrocycles containing pyridine and methylcarboxylate or methylphosphonate pendant arms | |
WO2002009771A1 (en) | Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex | |
AU2001276677A1 (en) | Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex | |
Chervu et al. | Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication | |
Kasina et al. | Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate) | |
Mirković et al. | Novel tetradentate diamine dioxime ligands: synthesis, characterization and in vivo behavior of their 99mTc‐complexes | |
Chakravarty et al. | Technetium-99m amino acid chelates: Correlation of their physico-chemical and physiological parameters. Part I. | |
Djokić et al. | Chemical and biological evaluation of 99m Tc (CO) 3 and 99m Tc complexes of some IDA derivatives | |
Jalilian et al. | Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection | |
Jansholt et al. | Catabolism and protein binding of Tc-99m pyridoxylideneglutamate | |
Baldas et al. | Preparation, HPLC studies and biological behaviour of 99mTc-and 99mTcN-radiopharmaceuticals based on quinoline type ligands |